INHIBIKASE THERAPEUTICS, INC.

Transcripts Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq Other stock markets 02:00:00 28/06/2024 am IST			5-day change	1st Jan Change
1.37 ^USD	-2.84%		-4.20%	+7.87%

17/06	Inhibikase Therapeutics Completes Enrollment of the Phase 2 ?201? Trial Evaluating Risvodetinib in Untreated Parkinson?s Disease	CI
05/06	Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline	CI

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Transcript : Inhibikase Therapeutics, Inc., Q1 2024 Earnings Call, May 16, 2024	16/05
Transcript : Inhibikase Therapeutics, Inc., 2023 Earnings Call, Mar 28, 2024	28/03
Transcript : Inhibikase Therapeutics, Inc., Q3 2023 Earnings Call, Nov 15, 2023	15/11
Transcript : Inhibikase Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023	15/23/15
Transcript : Inhibikase Therapeutics, Inc., Q1 2023 Earnings Call, May 16, 2023	16/23/16
Transcript : Inhibikase Therapeutics, Inc., Q4 2022 Earnings Call, Apr 03, 2023	03/23/03
Transcript : Inhibikase Therapeutics, Inc. - Special Call	22/23/22
Transcript : Inhibikase Therapeutics, Inc., Q3 2022 Earnings Call, Nov 15, 2022	15/22/15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer